Annual Gross Profit
$221.67 M
+$92.31 M+71.35%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual gross profit is $221.67 million, with the most recent change of +$92.31 million (+71.35%) on December 31, 2022.
- During the last 3 years, EGRX annual gross profit has risen by +$86.68 million (+64.21%).
- EGRX annual gross profit is now at all-time high.
Performance
EGRX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$47.79 M
-$1.22 M-2.48%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly gross profit is $47.79 million, with the most recent change of -$1.22 million (-2.48%) on June 30, 2023.
- Over the past year, EGRX quarterly gross profit has dropped by -$2.68 million (-5.32%).
- EGRX quarterly gross profit is now -45.77% below its all-time high of $88.12 million, reached on March 31, 2022.
Performance
EGRX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$179.88 M
-$2.68 M-1.47%
June 30, 2023
Summary
- As of February 8, 2025, EGRX TTM gross profit is $179.88 million, with the most recent change of -$2.68 million (-1.47%) on June 30, 2023.
- Over the past year, EGRX TTM gross profit has dropped by -$20.32 million (-10.15%).
- EGRX TTM gross profit is now -18.86% below its all-time high of $221.67 million, reached on December 31, 2022.
Performance
EGRX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
EGRX Gross Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +71.3% | -5.3% | -10.2% |
3 y3 years | +64.2% | +65.9% | +38.5% |
5 y5 years | +23.5% | +17.3% | +33.3% |
EGRX Gross Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +71.3% | -45.8% | +59.2% | -18.9% | +39.0% |
5 y | 5-year | at high | +71.3% | -45.8% | +65.9% | -18.9% | +39.0% |
alltime | all time | at high | >+9999.0% | -45.8% | +7411.5% | -18.9% | >+9999.0% |
Eagle Pharmaceuticals Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | $47.79 M(-2.5%) | $179.88 M(-1.5%) |
Mar 2023 | - | $49.01 M(+20.0%) | $182.56 M(-17.6%) |
Dec 2022 | $221.67 M(+71.4%) | $40.83 M(-3.4%) | $221.67 M(+5.1%) |
Sep 2022 | - | $42.25 M(-16.3%) | $210.85 M(+5.3%) |
Jun 2022 | - | $50.47 M(-42.7%) | $200.20 M(+7.0%) |
Mar 2022 | - | $88.12 M(+193.6%) | $187.09 M(+44.6%) |
Dec 2021 | $129.37 M(-9.1%) | $30.01 M(-5.0%) | $129.37 M(-5.4%) |
Sep 2021 | - | $31.59 M(-15.4%) | $136.73 M(-4.4%) |
Jun 2021 | - | $37.37 M(+22.9%) | $143.08 M(+6.4%) |
Mar 2021 | - | $30.39 M(-18.7%) | $134.51 M(-5.5%) |
Dec 2020 | $142.34 M(+5.4%) | $37.38 M(-1.5%) | $142.34 M(+0.5%) |
Sep 2020 | - | $37.94 M(+31.7%) | $141.63 M(+9.0%) |
Jun 2020 | - | $28.80 M(-24.6%) | $129.91 M(-4.8%) |
Mar 2020 | - | $38.22 M(+4.2%) | $136.53 M(+1.1%) |
Dec 2019 | $135.00 M(-10.8%) | $36.67 M(+39.8%) | $135.00 M(-0.6%) |
Sep 2019 | - | $26.23 M(-26.0%) | $135.82 M(-8.2%) |
Jun 2019 | - | $35.42 M(-3.5%) | $147.95 M(-3.5%) |
Mar 2019 | - | $36.69 M(-2.2%) | $153.26 M(+1.2%) |
Dec 2018 | $151.40 M(-15.7%) | $37.50 M(-2.2%) | $151.40 M(+3.0%) |
Sep 2018 | - | $38.35 M(-5.9%) | $146.98 M(-8.1%) |
Jun 2018 | - | $40.74 M(+17.0%) | $159.99 M(+2.9%) |
Mar 2018 | - | $34.82 M(+5.3%) | $155.54 M(-13.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2017 | $179.52 M(+33.8%) | $33.08 M(-35.6%) | $179.52 M(-14.0%) |
Sep 2017 | - | $51.36 M(+41.5%) | $208.76 M(+13.0%) |
Jun 2017 | - | $36.29 M(-38.3%) | $184.82 M(+3.8%) |
Mar 2017 | - | $58.80 M(-5.7%) | $177.97 M(+32.6%) |
Dec 2016 | $134.18 M(+165.3%) | $62.32 M(+127.4%) | $134.18 M(+53.5%) |
Sep 2016 | - | $27.41 M(-6.9%) | $87.44 M(+41.0%) |
Jun 2016 | - | $29.45 M(+96.3%) | $62.01 M(+76.1%) |
Mar 2016 | - | $15.00 M(-3.7%) | $35.22 M(-30.4%) |
Dec 2015 | $50.58 M(+584.9%) | $15.58 M(+685.8%) | $50.58 M(+40.1%) |
Sep 2015 | - | $1.98 M(-25.3%) | $36.11 M(+3.9%) |
Jun 2015 | - | $2.65 M(-91.3%) | $34.76 M(-4.4%) |
Mar 2015 | - | $30.36 M(+2632.8%) | $36.34 M(+376.4%) |
Dec 2014 | - | $1.11 M(+74.6%) | $7.63 M(+3.3%) |
Sep 2014 | $7.38 M(+17.3%) | $636.20 K(-85.0%) | $7.39 M(-12.7%) |
Jun 2014 | - | $4.24 M(+157.5%) | $8.46 M(+32.7%) |
Mar 2014 | - | $1.65 M(+89.5%) | $6.37 M(+8.1%) |
Dec 2013 | - | $868.00 K(-49.2%) | $5.89 M(-6.4%) |
Sep 2013 | $6.30 M(-1104.5%) | $1.71 M(-20.5%) | $6.30 M(+37.2%) |
Jun 2013 | - | $2.15 M(+84.1%) | $4.59 M(+88.1%) |
Mar 2013 | - | $1.17 M(-8.2%) | $2.44 M(+91.8%) |
Dec 2012 | - | $1.27 M | $1.27 M |
Sep 2012 | -$627.00 K | - | - |
FAQ
- What is Eagle Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual gross profit year-on-year change?
- What is Eagle Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly gross profit year-on-year change?
- What is Eagle Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals TTM gross profit year-on-year change?
What is Eagle Pharmaceuticals annual gross profit?
The current annual gross profit of EGRX is $221.67 M
What is the all time high annual gross profit for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual gross profit is $221.67 M
What is Eagle Pharmaceuticals annual gross profit year-on-year change?
Over the past year, EGRX annual gross profit has changed by +$92.31 M (+71.35%)
What is Eagle Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of EGRX is $47.79 M
What is the all time high quarterly gross profit for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly gross profit is $88.12 M
What is Eagle Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, EGRX quarterly gross profit has changed by -$2.68 M (-5.32%)
What is Eagle Pharmaceuticals TTM gross profit?
The current TTM gross profit of EGRX is $179.88 M
What is the all time high TTM gross profit for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high TTM gross profit is $221.67 M
What is Eagle Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, EGRX TTM gross profit has changed by -$20.32 M (-10.15%)